Decision-making about the use of non-vitamin K oral anticoagulant therapies for patients with atrial fibrillation
Crossref DOI link: https://doi.org/10.1007/s11239-015-1276-5
Published Online: 2015-09-05
Published Print: 2016-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Eckman, Mark H.
Funding for this research was provided by:
Pfizer Medical Education Group
Bristol-Myers Squibb/Pfizer Education Consortium
NIH/NCATS (8UL1TR000077-05)
Text and Data Mining valid from 2015-09-05